**The Biobank: A Step Forward for Biological Research**
A recent significant achievement in the field of biomedicine has been reached by the biobank of a well-known Italian research institute. This facility has obtained Accredia accreditation, a recognition that attests to excellence in the management and preservation of biological material of human origin. This milestone represents a significant advance for the scientific community and offers new opportunities for research on genetic diseases.
The accreditation obtained is based on the international standard UNI EN ISO 20387:2024, which establishes the standards for managing various types of biological materials. Examples include peripheral blood, serum, plasma, peripheral blood mononuclear cells (PBMC), urine, cerebrospinal fluid, genomic DNA, and cell lines. These materials, along with associated clinical data, are essential for research, as they come from subjects affected by genetic diseases.
The biobank in question is the second in Italy to receive such accreditation, following another facility that pioneered this field. The main objective is to collect, preserve, manage, and distribute biological samples in an organized manner that complies with regulations, thus contributing to the advancement of research and development in the biotechnology sector.
Research biobanks have the responsibility of managing not only the biological materials but also the related clinical data. This is essential to ensure the reproducibility and comparability of scientific results. For research outcomes to be considered valid, users must be assured that the samples are handled with utmost care and according to standardized procedures. These procedures concern every phase of the process: from collection to transport, from storage to traceability, up to the final distribution of the samples.
To meet these needs, the standard UNI ISO 20387:2019 “Biotechnology – Biobanking – General requirements for biobanking” establishes general requirements for competence, impartiality, and consistency in the functioning of biobanking facilities. This regulation provides a broad international framework for the management of biological samples and serves as the foundation for accreditation requests. The adoption of such standards not only ensures that biobanks adhere to high quality standards but also promotes a uniform and globally recognized approach.
The biobank in question is part of a context of growing attention at both national and international levels, contributing significantly to the improvement of scientific research and the development of new biotechnologies. The importance of accreditation should not be underestimated, as it provides a guarantee of quality and reliability, fundamental elements for research projects that could have a profound impact on human health.
The biotechnology sector, in particular, is emerging as one of the most promising globally. According to projections from the Organisation for Economic Co-operation and Development (OECD), by 2030, this sector could significantly influence the global economy, contributing about 2.7% to global gross domestic product (GDP). This promising scenario underscores the necessity of developing adequate research infrastructures and investing in biobanks that can support studies and trials for the future.
In conclusion, biobanks represent a crucial element in the landscape of biomedical research. By providing tangible support to scientific studies and research projects, they offer valuable resources that can facilitate potentially curative discoveries. This trend presents a real opportunity for scientists and researchers who, through access to high-quality biological material, can move closer to new therapeutic solutions.
We invite readers to follow our social media profiles to stay updated on the latest news in the field of biobanks and biological research. Sharing information and discoveries is essential to promote scientific progress and collective well-being.
